Delivery Order SPE2DB22D3016-SPE2DB24FAQC1

Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 200 MG TABLET 60S. The $8,026.69 award has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the prime on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to supply TOPAMAX 50 MG TABLET 60S medication. The $10,915.77 award has an ultimate completion date of April 11, 2024 and is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $60,330.75 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product, with a completion date of February 1, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract (SPE2DX15D3012|SPE2DX24F8LM0) by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The award, valued at $3,258.72, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,597.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Topamax 50 mg tablets. This contract is a task order issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to supply...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TOPAMAX 100 MG TABLET 60S. The order has a completion date of February 9, 2024 and a potential value of $4,433.10. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,110,277 units of the pharmaceutical product TOPAMAX 25 MG SPRINKLE CAP 60S. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $1,559.40. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00, which serves as the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,040.53 for the supply of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. The $4,075.26 contract has a completion date of February 12, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 25 MG TABLET 60S, a pharmaceutical product. The $2,494.75 contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAQC1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024.

Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not have any set-aside designations and was awarded solely to Amerisourcebergen Drug Corp.

Generated 6/14/24, 9:44 AM